NEW YORK (GenomeWeb News) - Stem cell research tools company Aruna Biomedical said yesterday that it has hired recently formed life sciences advisory and investment services firm RiversEdge BioVentures to evaluate strategic alternatives for Aruna.

RiversEdge will evaluate potential fundraising opportunities for Aruna, expansion of its strategic partnerships, and potential combinations with strategic and financial investors, among other services.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Publication of He Jiankui's work on gene-edited infants would raise ethical concerns for journals, Wired and others report.

The New York Times reports that evidence linking trauma in one generation to epigenetic effects that influence subsequent generations may be overstated.

ScienceInsider reports that US National Institutes of Health researchers were told in the fall they could not obtain new human fetal tissue.

In PNAS this week: skin pigmentation evolution among KhoeSan, biomarkers for dengue virus progression, and more.

Jan
31
Sponsored by
Roche

This webinar highlights the use of single-cell genomics to identify distinct cell types and states associated with enhanced immunity.